Article info

Download PDFPDF

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis

Authors

  1. a Hamzah_abusbeih{at}hotmail.com
  2. b faisalshaukatali{at}gmail.com
  3. c xuewang{at}mdanderson.org
  4. d Niharika.Mallepally{at}bcm.edu
  5. e Ellie.Chen{at}bcm.edu
  6. f MAltan{at}mdanderson.org
  7. g rbresali{at}mdanderson.org
  8. h alinepish{at}hotmail.com
  9. i RDadu{at}mdanderson.org
  10. j AAJazaeri{at}mdanderson.org
  11. k LASHNEB{at}ccf.org
  12. l (713) 794-5073 ywang59{at}mdanderson.org
View Full Text

Citation

Abu-Sbeih H, Ali FS, Wang X, et al
Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis

Publication history

  • Received January 31, 2019
  • Accepted March 22, 2019
  • First published April 2, 2019.
Online issue publication 
April 02, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.